Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls-Reference-Cited by-同舟云学术

Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls

Published:2021-08-06 Issue:9 Volume:20 Page:4303-4317
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Jasbi Paniz¹^ORCID,Shi Xiaojian¹²^ORCID,Chu Ping,Elliott Natalie,Hudson Haley,Jones Douglas,Serrano Geidy³,Chow Brandon¹,Beach Thomas G.³,Liu Li⁴⁵,Jentarra Garilyn⁶,Gu Haiwei¹^ORCID

Affiliation:

1. Arizona Metabolomics Laboratory, College of Health Solutions, Arizona State University, 850 N 5th Street, Phoenix, Arizona 85004, United States

2. Systems Biology Institute, Cellular and Molecular Physiology, Yale School of Medicine, West Haven, Connecticut 06516, United States

3. Banner Sun Health Research Institute, Sun City, Arizona 85351, United States

4. College of Health Solutions, Biodesign Institute, Arizona State University, Tempe, Arizona 85281, United States

5. Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, United States

6. Precision Medicine Program, Midwestern University, 19555 N 59th Avenue, Glendale, Arizona 85308, United States

Funder

National Institute of Neurological Disorders and Stroke

Arizona Department of Health Services

Midwestern University

Michael J. Fox Foundation for Parkinson's Research

National Institute on Aging

Arizona Biomedical Research Commission

College of Health Solutions

Banner Sun Health Research Institute

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.1c00290

Reference87 articles.

1. The epidemiology of the dementias: an update

2. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer’s disease: a pilot study

3. Development of Beta-Amyloid-induced Neurodegeneration in Alzheimer's Disease and Novel Neuroprotective Strategies

4. A Multi-Center Study of ACE and the Risk of Late-Onset Alzheimer's Disease

5. Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fueling Alzheimer’s Disease: Where Does Immunometabolism Stand?;Journal of Alzheimer's Disease;2024-08-20

2. Regional Differences in Microbial Infiltration of Brain Tissue from Alzheimer’s Disease Patients and Control Individuals;Brain Sciences;2024-07-03

3. Gut microbiome remodeling and metabolomic profile improves in response to protein pacing with intermittent fasting versus continuous caloric restriction;Nature Communications;2024-05-28

4. Branched-chain amino acids and the risks of dementia, Alzheimer’s disease, and Parkinson’s disease;Frontiers in Aging Neuroscience;2024-04-10

5. Inverse‐Vaccines for Rheumatoid Arthritis Re‐establish Metabolic and Immunological Homeostasis in Joint Tissues;Advanced Healthcare Materials;2024-03-19